This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Convatec has outlined plans to invest more than $1 billion in research and development facilities in the U.S. and U.K. over the next decade. The commitment, which the company made last week, includes $600 million that is earmarked for U.S. activities. Convatec is planning to increase its capacity in Boston by 50%. In the U.K., Convatec is moving R&D f ...